Medication info
Eurosoto 10 mg (Rosuvastatin Calcium)

Eurosoto 10 mg (Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Yuyoung Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
28 tablets (14 tablets/PTP (AluAlu) packaging X 2)
Approval status
Active

MFDS item code 201400757 · Approved 2014.02.19 · Insurance code 648203720

Summary

Main use
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, up to a maximum of 20 milligrams once daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Child dose
Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Younger than 10 years: Safety and efficacy have not been established.

Ingredients

Manufacturer
Yuyoung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • and family history of early coronary heart disease.
View approved original text

This medication is used as an adjunct to diet and exercise for patients with hypercholesterolemia and hyperlipidemia that cannot be managed by diet and exercise alone. It is effective in lowering total cholesterol and low-density lipoprotein (LDL) cholesterol levels, thus slowing the progression of atherosclerosis in patients with primary hypercholesterolemia, familial hypercholesterolemia, mixed hyperlipidemia, and dysbetalipoproteinemia. It is also used for pediatric patients aged 10 years and older with familial hypercholesterolemia to reduce cholesterol levels. This medication helps lower the risk of stroke, myocardial infarction, and arterial revascularization surgery in patients at high risk for cardiovascular disease. Therefore, it is an important treatment for managing cholesterol levels and cardiovascular disease risk.

How to take

Adult dose

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, up to a maximum of 20 milligrams once daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Child dose

Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Younger than 10 years: Safety and efficacy have not been established.

Precautions

This medication should not be administered to certain patients. For example, patients allergic to any ingredient of this medication, those with liver dysfunction, muscle diseases, severely impaired kidney function, or women who are pregnant or nursing should not use it. Additionally, high doses of this medication are contraindicated for patients who are susceptible to myopathy or rhabdomyolysis or have certain genetic disorders. Patients with lactose intolerance should also be cautious. Patients with a history of liver disease or excessive alcohol consumption should have regular liver function tests while taking this medication, and those with hypothyroidism should treat that condition before beginning treatment. This medication may cause muscle-related side effects such as myalgia or muscle weakness, so if these symptoms occur, patients should consult a physician immediately, and blood tests may be necessary to check for muscle damage. Elderly patients, those with kidney impairment, or those with a history of alcohol misuse require careful monitoring during treatment due to a higher risk of muscle side effects. This medication can also affect liver function. If symptoms of liver damage occur, the medication should be discontinued immediately. Moreover, the concentration in the blood may change depending on other medications taken simultaneously, which may increase the risk of muscle side effects. Therefore, patients must inform healthcare professionals about any concomitant medications and exercise caution. Women of childbearing potential should use adequate contraception and should not use this medication during pregnancy. In cases of overdose, there is no specific antidote; therefore, symptomatic treatment and monitoring of liver function and muscle enzyme levels are necessary. Caution is advised when driving or operating machinery due to potential dizziness.

Side effects

Angioedema, hypersensitivity reaction, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, muscle disease, rhabdomyolysis, asthenia, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, morbilliform drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immunemediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, ALT elevation, chest pain, muscle cramps, gout, erectile dysfunction, AST elevation, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. Additionally, avoid storing it in extremely hot or cold places, ideally at temperatures between 1°C and 30°C.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

28 tablets (14 tablets/PTP (AluAlu) packaging X 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.